The Who

---

Hydroxychloroquine has received worldwide attention after Donald Trump

A malaria drug that was tested as a treatment for coronavirus does not save lives, One of The World 's largest studies shows.

Hydroxychloroquine received worldwide attention after he retracted promoted by Donald Trump , And Then controversy after the studies have been on you.

The product has been pulled from the University of Oxford.

The findings were forwarded to The World health organization.

Back to the beginning of the pandemic, laboratory studies had suggested that malaria drug could impact on The Virus Small-scale studies in China and France, indicated then that it might help patients.

It was a huge amount of hope, as The Medicine is cheap and safe for the treatment of malaria and diseases such as lupus and arthritis.

However, The Evidence for its use for coronavirus was weak.

'has No treatment for the Covid'

This is the reason why the data of The Recovery study is crucial. It is The First test of the drug in a large number of people in a thorough clinical study.

More Than 11,000 patients with Covid-19 are involved, with 1,542 patients hydroxychloroquine given.

Due to the increasing controversy surrounding the drug, the British drug regulator Last Night , asked the Oxford researchers to check their data.

The results showed, 25. 7% of people had been taking hydroxychloroquine, died after 28 Days . This compared with 23. 5% is the standard treatment in the hospital.

"This is not a treatment for Covid," said Prof Martin Landray, part of The Recovery study. The attempt immediately stopped using the drug.

The findings in The Wake of the deep concern in academic publishing led to an article to be retracted is One of The World 's most respected medical journals.

It had published a study of almost 15 000 patients from hundreds of hospitals, given hydroxycholoroquine, or similar drug chloroquine.

they came to the conclusion that the drug was not beneficial and increases The Risk of cardiac arrhythmia and death. The publication led to THE suspension of the studies of the anti-malaria drug.

The data has been collected from the hospitals by the little-known healthcare company, Surgisphere.

"Disappointing,"

have been said concerns about the data, And Then some of the authors of the study, and could not stand, would not allow their publication as a Surgisphere that an independent review.

are Then retracted, and another paper had the data based on Surgisphere.

Prof Peter Horby of the Oxford University, which is running on The Recovery study, said: "Hydroxychloroquine and chloroquine have received a lot of attention and were very widely used for the treatment of Covid patients, despite The Absence of good information.

"it is not allowed disappointing that this treatment has proved ineffective, to focus, care, and research on other promising drugs. "

to follow on Twitter .

malaria, self-isolation, coronavirus pandemic, donald trump, medicine, university of oxford, medical research

Source of news: bbc.com